h-d-phe-pip-arg-pna has been researched along with aspirin in 2 studies
| Studies (h-d-phe-pip-arg-pna) | Trials (h-d-phe-pip-arg-pna) | Recent Studies (post-2010) (h-d-phe-pip-arg-pna) | Studies (aspirin) | Trials (aspirin) | Recent Studies (post-2010) (aspirin) |
|---|---|---|---|---|---|
| 95 | 1 | 5 | 48,947 | 6,817 | 13,778 |
| Protein | Taxonomy | h-d-phe-pip-arg-pna (IC50) | aspirin (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.35 | |
| Integrin beta-3 | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.8252 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 1.375 | |
| Integrin alpha-IIb | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.271 | |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | 2.4 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 2.15 | |
| Urotensin-2 receptor | Rattus norvegicus (Norway rat) | 0.3 | |
| 4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | 2.4 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.35 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.4081 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeWind, SA; Herrmann, EC; Leach, RD; Slattery, CW | 1 |
| Hirasawa, Y; Ito, K; Kato, Y; Kita, Y; Motoyama, Y; Nishio, M; Seki, J; Yamanaka, T | 1 |
2 other study(ies) available for h-d-phe-pip-arg-pna and aspirin
| Article | Year |
|---|---|
Choline inhibition of prothrombin activation.
Topics: Aspirin; Calcium; Choline; Dipeptides; Enzyme Activation; Factor Xa Inhibitors; Humans; Kinetics; Liposomes; Microcomputers; Phospholipids; Prothrombin; Spectrophotometry; Thromboplastin | 1991 |
In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
Topics: Arginine; Aspirin; Benzamides; Dipeptides; Dose-Response Relationship, Drug; Humans; Oligopeptides; Peptide Fragments; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Serine Endopeptidases; Sulfonamides; Thiazoles; Thiazolidines; Thrombin | 1999 |